Synthetic Biology grants

Open

Funds German small and medium-sized enterprises protecting their own research and development results with patents and other industrial property rights through WIPANO.

Open

Funds German companies with up to 1,000 employees taking part in national, European, and international standardization committees through WIPANO.

Open

Funds German small businesses preparing technology concepts for future project development and commercialization planning.

Open

Supports German innovation ecosystems by funding management of networks that connect multiple companies and institutions.

Scheduled

Funds investigator-led biotechnology projects in India advancing frontier biology through competitive grant pathways and programme review cycles.

Scheduled

Funds two €6M projects that use biotechnology to purify captured carbon and turn it into sustainable feedstock for industrial products.

Between cycles

Invests research teams and institutions for EB Research Project Grants in biotechnology, medical technology, and synthetic biology.

Between cycles

Funds developing and validating gene-editing tools in animal and other model systems used to study the human brain.

Between cycles

Funds early Indian biotech enterprises in pre-commercial research collaboration with innovation partners.

Between cycles

Funds late stage deep tech start ups and small businesses with combined non dilutive and growth support across technology fields.

Between cycles

Funds United States deep-tech startups demonstrating scientific feasibility of novel science and engineering innovations.

Between cycles

Funds United States deep-tech startups partnering with nonprofit research institutions for early-stage feasibility studies.

Between cycles

Supports United States deep-tech startups through a combined early and continuation development route.

Between cycles

Funds United States deep-tech startups extending proven early projects into substantial technology development.

Between cycles

Funds United States deep-tech projects that continue with nonprofit research partners after successful initial feasibility work.

Between cycles

Funds innovative SME-led international R&D consortia through the Eurostars Call 12 grant process.

Between cycles

Funds high-impact collaborative Huntington disease teams tackling complex mechanisms and novel therapeutic strategies with advanced team science.

Between cycles

Funds production and distribution of brain cell-type-specific reagents to institutions with broad access goals.

Between cycles

Supports Japanese startups demonstrating mass production readiness and scalable commercialization models.

Between cycles

Funds Japanese startups validating prototypes and testing market fit for deep-tech products and services.

Between cycles

Funds Japanese startups through early research development for core technology creation in emerging industries.

Between cycles

Funds bottom-up research for breakthrough deep-tech, any field of science.

Pays $100,000, and up to $10 million if patentable, for solving the origin of genetic code.

Between cycles

Supports United Kingdom industry-academia teams through partnership awards for precommercial innovation experiments.